Yanlei Zhang

Highly Selective Inhibition of Tyrosine Kinase 2 (TYK2) for the Treatment of Autoimmune Diseases: Discovery of the Allosteric Inhibitor BMS-986165

Stephen T. Wrobleski, Ryan Moslin, Shuqun Lin et al. · Journal of Medicinal Chemistry · 2019 · 369 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Donor-Derived CD7 Chimeric Antigen Receptor T Cells for T-Cell Acute Lymphoblastic Leukemia: First-in-Human, Phase I Trial

Jing Pan, Yue Tan, Guoling Wang et al. · Journal of Clinical Oncology · 2021 · 294 citations

Life Sciences, Hematology, Immunology +15

CD22 CAR T-cell therapy in refractory or relapsed B acute lymphoblastic leukemia

Jing Pan, Qing Niu, Biping Deng et al. · Leukemia · 2019 · 251 citations · Full text

Medicine, Hematology, Oncology +17

Sequential combination of photocatalysis and microalgae technology for promoting the degradation and detoxification of typical antibiotics

Chenguang Li, Tian Qian, Yanlei Zhang et al. · Water Research · 2021 · 165 citations

Engineering, Biotechnology, Chemical Engineering +16

Role of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Predicting the Adverse Effects of Chimeric Antigen Receptor T Cell Therapy in Patients with Non-Hodgkin Lymphoma

Jiasheng Wang, Yongxian Hu, Shuye Yang et al. · Biology of Blood and Marrow Transplantation · 2019 · 131 citations · Full text

Medicine, Immunology, Oncology +16